Anavex Life Sciences Corp (AVXL)

[falconer66a]

Eventually....

...Anavex isn't getting the love on the AD front like those other two but that is a temporary situation and when it changes it will change in a big way.

Exactly! The Anavex (blarcamesine) data are now solid. No one is endangering their reputations by trying to post any real biological reasons blarcamesine won’t be able to successfully treat Alzheimer’s. A few will claim “more clinical testing is needed.” But that’s not biological; it’s regulatory procedure.

Soon enough, the results of all the blarcamesine clinical trials will be released. As in the past, they will be profoundly positive, but this time from large clinical populations. The game changes then. The other therapeutic players are disqualified; can’t play or compete in the same arena.

But a matter of time.